Table 2.
Demographic data on the participants in the different study groups.
| Demographic/MMSE Data | FH− | FH+ | ||||||
|---|---|---|---|---|---|---|---|---|
| ApoE ɛ4− | ApoE ɛ4+ | ApoE ɛ4− | ApoE ɛ4+ | |||||
| No HD | HD | No HD | HD | No HD | HD | No HD | HD | |
| Group 1.1 | Group 1.2 | Group 1.3 | Group 1.4 | Group 2.1 | Group 2.2 | Group 2.3 | Group 2.4 | |
| N | 29 | 14 | 9 | 5 | 57 | 17 | 35 | 18 |
| Age | 59.0 (54.0–65.0) | 62.5 (56.0–69.0) | 63.0 (54.0–70.0) | 63.0 (58.0–76.5) | 58.0 (53.0–62,0) | 63.0 (56.5–58.5) | 57.0 (57.0–65.0) | 55.5 (51.0–63.0) |
| Sex Male/Female | 12/17 | 6/8 | 3/6 | 0/5 | 22/35 | 6/11 | 11/24 | 9/9 |
| MMSE | 29.0 (28.0–29.0) | 29.0 (29.0–29.0) | 29.0 (28.0–30.0) | 29.0 (29.0–30.0) | 29.0 (28.5–29.0) | 29.0 (28.0–29.0) | 29.0 (29.0–29.0) | 29.0 (28.0–30.0) |
Median (interquartile range); FH+, subjects with a family history of Alzheimer’s disease (AD); FH−, subjects without a family history of AD; ApoE, Apolipoprotein E.